Multiple Keratoacanthoma-like Lesions in a Patient Treated with Pembrolizumab
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Dobre A, Nedelcu R, Turcu G, Brinzea A, Struna I, Tudorache G Am J Clin Dermatol. 2024; 26(1):45-59.
PMID: 39572470 PMC: 11742465. DOI: 10.1007/s40257-024-00900-0.
To treat or not to treat: PD-L1 inhibitor-induced keratoacanthoma and squamous cell carcinoma.
Poole M, Schwartz R, Lambert W, Alhatem A Arch Dermatol Res. 2022; 315(4):903-915.
PMID: 36394634 DOI: 10.1007/s00403-022-02468-3.